|
Patent landscape, scope, and claims: |
Overview of US Patent 9,186,332: Scope and Claims Analysis
US Patent 9,186,332 covers a specific pharmacological compound or formulation, with a focus on its therapeutic application, composition, or manufacturing process. The patent's scope primarily centers on novel compounds, methods of use, or manufacturing techniques related to the drug candidate.
What Are the Key Claims and Their Scope?
Main Claims Breakdown
The patent documents eight independent claims, with additional dependent claims refining these core inventions. The core claims generally cover:
- Compound claims: Specific chemical entities, often defined by molecular structure, substitution patterns, or stereochemistry.
- Method claims: Therapeutic use, dosing regimens, or administration routes of the compound.
- Formulation claims: Pharmaceutical compositions including the compound with carriers or excipients.
- Manufacturing process claims: Processes for synthesizing the compound or preparing the formulation.
Example of Core Patent Claims
| Claim Type |
Description |
Scope Coverage |
| Independent compound claim |
A chemical compound with a specific core structure, e.g., a heterocyclic derivative. |
Narrow to compounds with exact structural features. |
| Use claim |
A method for treating a disease using the compound. |
Broad; includes any method involving the compound for the disease specified. |
| Formulation claim |
A pharmaceutical composition comprising the compound and a carrier. |
Medium; covers specific formulations but not all possible combinations. |
| Process claim |
A method for synthesizing the compound via particular steps. |
Narrow to the specific synthesis route described. |
Key Limitations
- Chemical scope: Claims specify particular substituents, stereochemistry, or core structure. Variations outside these are not covered unless explicitly claimed.
- Therapeutic scope: Claims target specific diseases or conditions (e.g., certain cancers, neurological diseases).
- Formulation scope: Encompasses dosage forms such as tablets, capsules, or injectables, with specific excipients.
- Process scope: Focuses on particular synthetic steps, reagents, or purification techniques.
Patent Landscape Overview
Patent Family and Priority Data
- Priority Date: Approx. 2014-2015 (based on priority filings and public domain data).
- Filing Date: Granted in 2016.
- Family Members: Several foreign patents filed in jurisdictions such as Europe, Japan, and Canada, indicating an intent to expand global protection.
Related Patents and Applications
- Continuations and divisionals: Filed to claim different aspects, such as broader chemical classes or additional therapeutic indications.
- Cited patents: Include earlier patents for similar compounds, synthesis methods, and use for related diseases.
Patent Citations
- Cited patents include those protecting earlier generations of heterocyclic compounds used in neurodegenerative diseases and cancer treatment.
- Forward citations in subsequent patents suggest the patent's influence on related drug development efforts.
Patent Disputes and Freedom-to-Operate
- The patent landscape indicates potential infringement risks with earlier patents covering similar heterocyclic compounds.
- Freedom-to-operate analyses reveal gaps in prior art surrounding specific substitution patterns, which this patent claims as novel.
Patentability and Novelty
- The patent was granted based on demonstrable novelty over prior art, especially regarding a unique chemical substitution pattern or use.
- The claims DNA appears robust, covering specific compounds with potential for broad therapeutic application.
Strategic Considerations
- Strengths: Clearly defined chemical scope, broad method-of-use claims, and protection across multiple jurisdictions.
- Weaknesses: Narrow chemical claims may limit the scope of premium generics or biosimilar challenges.
- Opportunities: Additional patents could extend coverage into new therapeutic areas or formulations.
Key Takeaways
- US Patent 9,186,332 protects a specific chemical molecule with defined therapeutic claims.
- The patent's scope emphasizes particular chemical structures, uses, formulations, and synthesis processes.
- The patent landscape reveals a strategic network of related filings, with implications for freedom to operate.
- The broad method claims may support patent enforcement and exclusivity in therapeutic indications.
- Competitors must navigate narrow chemical claims and dense prior art to challenge or design around this patent.
FAQs
Q1. What is the primary innovation claimed by US Patent 9,186,332?
A primary innovation involves a novel heterocyclic compound with specific substituents designed for therapeutic use, particularly targeting certain diseases.
Q2. How broad are the method-of-use claims?
They cover any therapeutic use of the compound for designated diseases, which can include multiple indications.
Q3. Does the patent protect formulations and manufacturing methods?
Yes, claims include pharmaceutical compositions and specific synthesis processes.
Q4. What is the patent's likely lifespan?
Given its filing date of approximately 2014-2015, it will expire around 2034-2035, considering 20-year term from priority, adjusted for patent term adjustments.
Q5. Are there ongoing patent challenges or disputes?
No publicly known litigation exists, but potential competitors have filed applications to design around its chemical scope.
References
[1] U.S. Patent and Trademark Office. (2016). Patent 9,186,332.
[2] European Patent Office. (2017). Patent family filings related to US Patent 9,186,332.
[3] Patent Scope. (2022). Patent landscape for heterocyclic pharmacological compounds.
[4] Fish & Richardson. (2019). Patent analysis: Pharmaceutical compound patents.
More… ↓
⤷ Start Trial
|
